Please login (Members) to view content or
(Nonmembers) this article.
No votes yet
Advanced Practice Nursing Issues

Fecal Microbiota Transplantation in Patients With Cancer Undergoing Treatment

Lisa M. Blackburn
Andrea Bales
Mary Caldwell
Lee Cordell
Susan Hamilton
Haley Kreider
CJON 2015, 19(1), 111-114 DOI: 10.1188/15.CJON.111-114

Fecal microbiota transplantation (FMT) is a technique used to restore the normal body flora to the gut in cases of Clostridium difficile infection (CDI). It involves instillation of the stool of a healthy donor through a nasogastric tube or colonoscopy into the gastrointestinal tract of the patient. More research is needed to determine the parameters of FMT use in patients with cancer.

At a Glance

  • CDI is common in patients with cancer because of the frequent use of broad-spectrum antibiotics that can alter the normal microbiota in the gastrointestinal tract.
  • CDI reoccurs frequently and can be difficult to treat.
  • CDI can delay continued treatment, prolong hospitalizations, and greatly affect a patient’s quality of life.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or